Investment

Period Apparel Company Ruby Love Secures a New Round of Investment Led by SteelSky Ventures

New York-based period apparel company Ruby Love has recently closed a round of funding led by the women’s health fund SteelSky Ventures. Base10 also participated in the financing. The company had previously secured a $15 million Series A deal and has now added additional funding to grow its line of period underwear, swimsuits, loungewear, and active gear. The line of sustainable period wear expands the menstrual…

Willow Adds $26.8M in an Extended Series C Round to Invest in Product Development and Further Expansion

Willow, the company forever changing the way moms pump with the world’s first all-in-one, in-bra wearable breast pump with full spill-proof mobility, today announced an additional $26.8 Million in funding through a Series C Extension round –  led by Endeavour Vision, alongside NEA (New Enterprise Associates), Pura Vida Investments, Purple Arch Ventures (a part of Alumni Ventures Group), Logos Capital, and Gaingels. This extension…

Egg Donor Matching Platform Tulip Closes a $1.7M Seed Round

Tulip, the world’s largest egg donor database and trusted resource for intended parents to find their ideal donor, today announced the closing of a $1.7 Million seed round. Launched in November of 2020, Tulip has quickly amassed donors from 90% of the agencies in the U.S – with nearly 20,000 egg donors within its database. The user-friendly, online search platform helps intended…

Renovia Raises a $17M Series C for Its Pelvic Health Focused Digital Therapeutic leva

Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the closing of an additional round of equity funding totaling $17 million. The financing included new investor, Parian Global Management, along with existing Renovia investors, including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures. “We’re very pleased to continue working with such an accomplished group of…

French Femtech Startup Nabla Announces a €17M Funding Round to Continue Work on its App-Based Virtual Clinic

French Women’s Health Startup Nabla has raised €17M for its new app focused on women’s health. Nabla offers community content, chat-based support from an interdisciplinary team of health professionals, and helps users to centralize their medical data. Participating investors in the round include Xavier Niel, well-known for his efforts around startup hub Station F in Paris, Artemis, Rachel Delacour, Julie Pelle, Marc…

UK-based Hashiona raises a €450K Pre-Seed Round for its App-Based Virtual Clinic for Hashimoto Patients

London-based Hashimoto startup Hashiona has announced the close of a €450K pre-seed round. The company was founded in early 2020 and initially launched in January 2021. Hashiona has since acquired hundreds of beta-users, who use the app to track symptoms and connect with providers via telehealth. Draper University, KAYA, DFRI, Calm/Storm, as well as angel investors participated in the round. Hashimoto is an autoimmune disease…

Hybrid Care Women’s Health Platform Origin Announces Seed Funding and Nationwide Expansion in the U.S.

Origin, a women’s health platform providing physical therapy and expert guidance for issues specific to the female body, today announces aggressive growth plans following a seed funding round led by Brand Foundry Ventures and The Blue Venture Fund. The new investment will be used to accelerate Origin’s mission of ensuring women and mothers nationwide in the U.S. have access to specialized, expert…

Femtech Startup Yoppie raises a £1.2M Seed Round to Personalize Period Care

UK-based Yoppie, a DTC femtech company focused on subscription-based, organic period care and PMS products has recently announced a £1.2M seed round bringing total funding to £3.4M. The company has now been backed by Vostock New Ventures and Colle Capital. Since its start in 2016 the company has evolved from e-commerce to leveraging tech for logistics, personalization and customer education. The new…